The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy

BACKGROUND: Salivary gland carcinomas (SGC) are extremely rare malignancies with only limited treatment options for the metastatic phase of the disease. Treatment with anti-CD47 antibodies could represent a potent therapy for SGCs by promoting the phagocytic clearance of tumor cells through various...

Descripción completa

Detalles Bibliográficos
Autores principales: Votava, Michal, Bartolini, Robin, Capkova, Linda, Smetanova, Jitka, Jiri, Vachtenheim, Kuchar, Martin, Kalfert, David, Plzak, Jan, Bartunkova, Jirina, Strizova, Zuzana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520840/
https://www.ncbi.nlm.nih.gov/pubmed/36171566
http://dx.doi.org/10.1186/s12885-022-10114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520840/
https://www.ncbi.nlm.nih.gov/pubmed/36171566
http://dx.doi.org/10.1186/s12885-022-10114-4

Ejemplares similares